For citations:

Barbarash O.L., Kashtalap V.V. Risk management in patients with atrial fibrillation and comorbid conditions: potentialities of edoxaban. Russian Journal of Cardiology. 2020;25(10):4131. (In Russ.) https://doi.org/10.15829/1560-4071-2020-4131